Tekla Capital Management’s BioNTech BNTX Stock Holding History

Tekla Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$11.2M	Hold	103,858	–	–	0.44%	54
2023 Q1	$12.9M	Hold	103,858	–	–	0.49%	48
2022 Q4	$15.6M	Buy	103,858 +8,816	+9%	+$1.36M	0.59%	42
2022 Q3	$12.8M	Hold	95,042	–	–	0.52%	46
2022 Q2	$14.2M	Hold	95,042	–	–	0.56%	51
2022 Q1	$16.2M	Buy	95,042 +4,800	+5%	+$807K	0.57%	48
2021 Q4	$23.3M	Buy	90,242 +9,485	+12%	+$2.6M	0.75%	37
2021 Q3	$22M	Buy	80,757 +23,684	+41%	+$7.53M	0.71%	40
2021 Q2	$12.8M	Sell	57,073 -11,741	-17%	-$2.21M	0.42%	62
2021 Q1	$7.51M	Buy	+68,814	New	+$7.31M	0.26%	98
2020 Q4	–	Sell	-43,595	Closed	-$3.02M	–	205
2020 Q3	$3.02M	Buy	+43,595	New	+$3.13M	0.11%	131

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tekla Capital Management's BNTX Position: Q2 2023 in Review

Tekla Capital Management held its BioNTech (BNTX) position steady in Q2 2023 at 103,858 shares worth $11.2M. The position accounts for 0.44% of the portfolio, ranked #54.

Tekla Capital Management first reported a position in BNTX in Q3 2020 and has held it in 11 quarters since. The position peaked at $23.3M in Q4 2021. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

Tekla Capital Management held 103,858 shares of BioNTech worth $11.2M as of Q2 2023.
Tekla Capital Management left its BioNTech share count unchanged in Q2 2023.
BioNTech made up 0.44% of Tekla Capital Management's portfolio in Q2 2023, its #54 holding.
Tekla Capital Management first reported a position in BioNTech in Q3 2020 and has held it in 11 quarters since.
Tekla Capital Management's BioNTech position peaked at $23.3M in Q4 2021.
253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.